For example, hsa-miR-182, and hsa-miR-532 could suppresses RCC migration and proliferation respectively via targeting insulin-like growth factor 1 receptor (IGF1R), or nucleosome assembly protein 1-like 1 (NAP1L1) (44, 45). Here, NAP1L1 is linked to renal cell carcinoma.